In pancreatic cancer, numerous laminin studies have independently connected expression levels of single laminin genes with outcomes, although most have focused on pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene LAMB2 and pancreatic ductal adenocarcinoma.